Revance Therapeutics Inc (NASDAQ:RVNC)

21.22
Delayed Data
As of May 22
 +0.34 / +1.63%
Today’s Change
9.88
Today|||52-Week Range
27.97
+30.75%
Year-to-Date
No recent news for Revance Therapeutics Inc.

Today’s Trading

Previous close20.88
Today’s open20.88
Day’s range20.54 - 21.26
Volume50,435
Average volume (3 months)837,803
Market cap$1.2B
Data as of 3:59pm ET, 05/22/2020

Growth & Valuation

Earnings growth (last year)+6.93%
Earnings growth (this year)-30.21%
Earnings growth (next 5 years)--
Revenue growth (last year)-88.92%
P/E ratioNM
Price/Sales1,707.91
Price/Book4.94

Competitors

 Today’s
change
Today’s
% change
ESPREsperion Therapeutic...-0.49-1.12%
ARCTArcturus Therapeutic...+4.28+7.91%
MGNXMacroGenics Inc+0.21+0.83%
ZEALZealand Pharma A/S-0.10-0.29%
Data as of 4:57pm ET, 05/22/2020

Financials

Next reporting dateJuly 30, 2020
EPS forecast (this quarter)-$0.99
Annual revenue (last year)$413.0K
Annual profit (last year)-$159.4M
Net profit margin-38,602.66%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
No executives to display
Corporate headquarters
Newark, California

Forecasts